praziquantel has been researched along with Bancroftian Elephantiasis in 10 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two-arm comparative study in northern Ghana integrated praziquantel distribution into an existing lymphatic filariasis and onchocerciasis control programme using Community Directed Distributors." | 7.77 | Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis. ( Aborigo, R; Adjuik, M; Akweongo, P; Amankwa, J; Anto, F; Anyorigiya, T; Asoala, V; Bimi, L; Hodgson, A; Oduro, A, 2011) |
| "We assessed the impact of three annual vs five semiannual rounds of mass drug administration (MDA) with ivermectin plus albendazole followed by praziquantel for the control or elimination of lymphatic filariasis (LF), onchocerciasis, soil-transmitted helminth (STH) infections and schistosomiasis in Lofa County, Liberia." | 5.51 | Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia. ( Bolay, FK; Curtis, K; Eneanya, OA; Fischer, K; Fischer, PU; Gankpala, L; Goss, CW; Gray, EB; Momolu, AT; Nyan, ES; Weil, GJ, 2022) |
| " This study reports on the safety of a combination of albendazole, ivermectin and praziquantel in the treatment of lymphatic filariasis (LF), schistosomiasis and soil-transmitted helminthiasis (STH) in infected children." | 5.15 | A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda. ( Kabatereine, N; Namwanje, H; Olsen, A, 2011) |
| "Our data suggest that co-administration of ivermectin, albendazole and praziquantel is safe in areas where lymphatic filariasis, soil-transmitted helminthiasis and schistosomiasis are co-endemic and where several rounds of treatment with one or two drugs have been implemented in the past." | 5.13 | Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study. ( Biswas, G; Bradley, MH; Chitsulo, L; Engels, D; Gabrielli, AF; Haji, HJ; Mohammed, KA; Molyneux, DH; Mubila, L; Savioli, L, 2008) |
| "Two-arm comparative study in northern Ghana integrated praziquantel distribution into an existing lymphatic filariasis and onchocerciasis control programme using Community Directed Distributors." | 3.77 | Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis. ( Aborigo, R; Adjuik, M; Akweongo, P; Amankwa, J; Anto, F; Anyorigiya, T; Asoala, V; Bimi, L; Hodgson, A; Oduro, A, 2011) |
| " Age, underweight, and double dosing were associated with increase in ADE incidence, while gender and food intake were not associated with increase in ADE incidence." | 1.72 | Adverse drug effects among students following mass de-worming exercise involving administration of Praziquantel and Albendazole in KEEA Municipality, Ghana. ( Akrasi, W; Boye, A; Brah, AS; Essuman, MA; Osei, V, 2022) |
| "The combined effect of the Lymphatic Filariasis Elimination Programme (LFEP) and the National Schistosomiasis and Soil-transmitted Helminthiasis Control Programme (NSSCP) on soil-transmitted helminthiasis (STH) was evaluated." | 1.35 | The combined effect of the Lymphatic Filariasis Elimination Programme and the Schistosomiasis and Soil-transmitted Helminthiasis Control Programme on soil-transmitted helminthiasis in schoolchildren in Tanzania. ( Magnussen, P; Massa, K; Ndawi, B; Ntakamulenga, R; Olsen, A; Sheshe, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eneanya, OA | 1 |
| Gankpala, L | 1 |
| Goss, CW | 1 |
| Momolu, AT | 1 |
| Nyan, ES | 1 |
| Gray, EB | 1 |
| Fischer, K | 1 |
| Curtis, K | 1 |
| Bolay, FK | 1 |
| Weil, GJ | 1 |
| Fischer, PU | 1 |
| Akrasi, W | 1 |
| Brah, AS | 1 |
| Essuman, MA | 1 |
| Osei, V | 1 |
| Boye, A | 1 |
| Chami, GF | 1 |
| Kabatereine, NB | 1 |
| Tukahebwa, EM | 1 |
| Budge, PJ | 1 |
| Sognikin, E | 1 |
| Akosa, A | 1 |
| Mathieu, EM | 1 |
| Deming, M | 1 |
| Massa, K | 1 |
| Magnussen, P | 1 |
| Sheshe, A | 1 |
| Ntakamulenga, R | 1 |
| Ndawi, B | 1 |
| Olsen, A | 2 |
| Namwanje, H | 1 |
| Kabatereine, N | 1 |
| Anto, F | 1 |
| Asoala, V | 1 |
| Anyorigiya, T | 1 |
| Oduro, A | 1 |
| Adjuik, M | 1 |
| Akweongo, P | 1 |
| Aborigo, R | 1 |
| Bimi, L | 1 |
| Amankwa, J | 1 |
| Hodgson, A | 1 |
| Hopkins, DR | 1 |
| Eigege, A | 2 |
| Miri, ES | 1 |
| Gontor, I | 1 |
| Ogah, G | 1 |
| Umaru, J | 2 |
| Gwomkudu, CC | 1 |
| Mathai, W | 1 |
| Jinadu, M | 1 |
| Amadiegwu, S | 1 |
| Oyenekan, OK | 1 |
| Korve, K | 1 |
| Richards, FO | 1 |
| Mohammed, KA | 1 |
| Haji, HJ | 1 |
| Gabrielli, AF | 1 |
| Mubila, L | 1 |
| Biswas, G | 1 |
| Chitsulo, L | 1 |
| Bradley, MH | 1 |
| Engels, D | 1 |
| Savioli, L | 1 |
| Molyneux, DH | 1 |
| Pede, E | 1 |
| Miri, E | 1 |
| Ogbu Pearce, P | 1 |
| Jinadu, MY | 1 |
| Njepuome, AN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gaps in Helminth Control: Safety and Efficacy of Drug Combinations Against Triple Infections[NCT01050517] | 250 participants (Anticipated) | Interventional | 2007-10-31 | Completed | |||
| Can Anthelminthic Treatment Delay the Progression of HIV? Randomised Open-label Trial Testing Presumptive Anthelminthic Treatment on Progression of HIV in ART-naïve HIV-positive Patients in a Rural African Setting With Presumed High Prevalence of Helminth[NCT00817713] | 295 participants (Actual) | Interventional | 2009-01-31 | Terminated (stopped due to Terminated prematurely due to recruitment difficulties. Expansion to more study sites not planned.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for praziquantel and Bancroftian Elephantiasis
| Article | Year |
|---|---|
Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia.
Topics: Albendazole; Animals; Cross-Sectional Studies; Elephantiasis, Filarial; Helminthiasis; Humans; Iverm | 2022 |
A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.
Topics: Adolescent; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Cost-Benefit Analys | 2011 |
Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Child; Child, Preschool; Drug Therapy, Combination; E | 2008 |
7 other studies available for praziquantel and Bancroftian Elephantiasis
| Article | Year |
|---|---|
Adverse drug effects among students following mass de-worming exercise involving administration of Praziquantel and Albendazole in KEEA Municipality, Ghana.
Topics: Albendazole; Drug-Related Side Effects and Adverse Reactions; Elephantiasis, Filarial; Female; Ghana | 2022 |
The division of labour between community medicine distributors influences the reach of mass drug administration: A cross-sectional study in rural Uganda.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Community Hea | 2019 |
Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis.
Topics: Adolescent; Adult; Albendazole; Antiparasitic Agents; Child; Elephantiasis, Filarial; Female; Helmin | 2016 |
The combined effect of the Lymphatic Filariasis Elimination Programme and the Schistosomiasis and Soil-transmitted Helminthiasis Control Programme on soil-transmitted helminthiasis in schoolchildren in Tanzania.
Topics: Albendazole; Animals; Anthelmintics; Child; Drug Therapy, Combination; Elephantiasis, Filarial; Fema | 2009 |
Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
Topics: Adolescent; Albendazole; Child; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases | 2011 |
Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.
Topics: Anthelmintics; Elephantiasis, Filarial; Health Education; Health Knowledge, Attitudes, Practice; Hum | 2002 |
Triple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria.
Topics: Albendazole; Anthelmintics; Antiparasitic Agents; Cost-Benefit Analysis; Drug Interactions; Drug The | 2008 |